Document is current
Any future updates will be listed below
-
Authors
Hillege, Lars E. https://orcid.org/0000-0001-7010-7610
Barnett, David J. M. https://orcid.org/0000-0003-1961-7206
Ziemons, Janine https://orcid.org/0000-0002-4559-5488
Aarnoutse, Romy https://orcid.org/0000-0002-8713-9747
de Vos-Geelen, Judith https://orcid.org/0000-0003-2578-1766
van Geel, Robin https://orcid.org/0000-0003-1880-8131
de Boer, Maaike https://orcid.org/0000-0002-0835-8651
van Riet, Yvonne E. A.
Vincent, Jeroen
Penders, John https://orcid.org/0000-0001-9146-5919
Smidt, Marjolein L. https://orcid.org/0000-0002-8328-1869
- License Information
-
More Information
Article History
Received: 13 October 2024
Accepted: 24 February 2025
First Online: 6 March 2025
Declarations
:
: LEH, JZ, and MLS have received research funding from Danone Global Research & Innovation Center, outside the submitted work. Additionally, MLS, RA, and JVG have received funding from Servier, and MLS from Illumina, all outside the submitted work. JVG has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier, all outside the submitted work. JP has received research funding from Friesland Campina outside the submitted work. All other authors have no competing interests. All other authors have no competing interests.
: The study was approved by the Medical Ethics Committee of azM/UM and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All patients provided written informed consent.
